from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1353c/-

LFCtreatmentdescriptionclass of inhibitor

-0.400

Amikacinug/mL Amikacintranslation

0.165

Cap5-10ug/mL Capreomycintranslation

0.274

Rox10-50 ug/mL Roxithromycintranslation

1.062

SM2-5 ug/mL Streptomycintranslation

-0.069

Tet5-10 ug/mL Tetracyclinetranslation

0.410

Rif0.2-5ug/mL Rifampicintranscription

0.534

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.635

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.453

CPZ10-50 ug/mL Chlorpromazinerespiration

1.046

Clofazimine10-13 ug/mL Clofaziminerespiration

0.838

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.310

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.581

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.708

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.800

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.663

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.663

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.627

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.337

Nigericin50 uM Nigericinrespiration

0.052

TRC10-150 ug/mL Triclosanrespiration

1.771

TRZ10-25 ug/mL Thioridazinerespiration

0.175

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.670

menadione6-10 ug/mL Menadionerespiration

-0.052

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.140

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.335

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.117

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.055

NRP_1Non-replicating persistence stage 1dosRassociated

-0.603

Amp0.2mg/mL AmpicillincellWall

0.901

Cephalexin20-100 ug/mL CephalexincellWall

-0.335

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.298

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.360

EMB10-20 ug/mL EthambutolcellWall

-0.232

Eta12-40 ug/mL EthionamidecellWall

-0.103

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.230

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.722

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.663

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.302

BZA0.12 mg/mL BenzamidearomaticAmides

-0.261

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.085

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.314

H2O24 mM hydrogen peroxideDNAdamaging

0.071

Levo10 ug/mL LevofloxacinDNAdamaging

-0.440

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.100

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.225

UVUV-irradiationDNAdamaging

0.701

ARP41-4 ug/mL Antitubercular compound ARP4?

0.083

Antimycin12.5-50 ug/mL Antimycin A?

-0.756

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.101

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.049

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.086

PA8240.2-2 ug/mL PA-824?

-0.140

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.576

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.382

Verapamil50 uM Verapamil?

-1.982

mercaptoethanol2 mM 2-Mercaptoethanol?

0.169

methoxatin10-20 ug/mL Methoxatin?